IRF7 and breast cancer: Analysis of publicly available murine breast cancer bone metastasis datasets revealed that interferon regulatory factor Irf7, whose expression is repressed during bone metastasis (GSE37975), is upregulated by the SAM + 25(OH)D combination treatment.